Suppr超能文献

与亮氨酸重复激酶2(LRRK2)相关的帕金森病的认知概况。

Cognitive profile of LRRK2-related Parkinson's disease.

作者信息

Srivatsal Sindhu, Cholerton Brenna, Leverenz James B, Wszolek Zbigniew K, Uitti Ryan J, Dickson Dennis W, Weintraub Daniel, Trojanowski John Q, Van Deerlin Vivianna M, Quinn Joseph F, Chung Kathryn A, Peterson Amie L, Factor Stewart A, Wood-Siverio Cathy, Goldman Jennifer G, Stebbins Glenn T, Bernard Bryan, Ritz Beate, Rausch Rebecca, Espay Alberto J, Revilla Fredy J, Devoto Johnna, Rosenthal Liana S, Dawson Ted M, Albert Marilyn S, Mata Ignacio F, Hu Shu-Ching, Montine Kathleen S, Johnson Catherine, Montine Thomas J, Edwards Karen L, Zhang Jing, Zabetian Cyrus P

机构信息

Virginia Mason Neuroscience Institute, Seattle, Washington, USA.

出版信息

Mov Disord. 2015 Apr 15;30(5):728-33. doi: 10.1002/mds.26161. Epub 2015 Feb 4.

Abstract

BACKGROUND

Increasing evidence suggests that genetic factors play a role in the variability associated with cognitive performance in Parkinson's disease (PD). Mutations in the LRRK2 gene are the most common cause of monogenic PD; however, the cognitive profile of LRRK2-related PD is not well-characterized.

METHODS

A cohort of 1,447 PD patients enrolled in the PD Cognitive Genetics Consortium was screened for LRRK2 mutations and completed detailed cognitive testing. Associations between mutation carrier status and cognitive test scores were assessed using linear regression models.

RESULTS

LRRK2 mutation carriers (n = 29) demonstrated better performance on the Mini Mental State Examination (P = 0.03) and the Letter-Number Sequencing Test (P = 0.005). A smaller proportion of LRRK2 carriers were demented (P = 0.03).

CONCLUSIONS

Our cross-sectional study demonstrates better performance on certain cognitive tests, as well as lower rates of dementia in LRRK2-related PD. Future longitudinal studies are needed to determine whether LRRK2 mutation carriers exhibit slower cognitive decline. © 2015 International Parkinson and Movement Disorder Society.

摘要

背景

越来越多的证据表明,遗传因素在帕金森病(PD)认知功能的变异性中发挥作用。LRRK2基因突变是单基因帕金森病最常见的病因;然而,LRRK2相关帕金森病的认知特征尚未得到充分描述。

方法

对帕金森病认知遗传学联盟招募的1447名帕金森病患者进行队列研究,筛查LRRK2基因突变,并完成详细的认知测试。使用线性回归模型评估突变携带者状态与认知测试分数之间的关联。

结果

LRRK2突变携带者(n = 29)在简易精神状态检查表(P = 0.03)和字母数字排序测试(P = 0.005)中表现更好。LRRK2携带者中痴呆的比例较小(P = 0.03)。

结论

我们的横断面研究表明,LRRK2相关帕金森病患者在某些认知测试中表现更好,痴呆发生率更低。未来需要进行纵向研究,以确定LRRK2突变携带者的认知衰退是否更慢。© 2015国际帕金森病和运动障碍协会。

相似文献

1
Cognitive profile of LRRK2-related Parkinson's disease.
Mov Disord. 2015 Apr 15;30(5):728-33. doi: 10.1002/mds.26161. Epub 2015 Feb 4.
2
Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.
3
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.
Parkinsonism Relat Disord. 2012 Mar;18(3):243-6. doi: 10.1016/j.parkreldis.2011.10.009. Epub 2011 Nov 6.
4
Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.
Parkinsonism Relat Disord. 2015 May;21(5):494-9. doi: 10.1016/j.parkreldis.2015.02.019. Epub 2015 Mar 2.
5
Progression in the LRRK2-Asssociated Parkinson Disease Population.
JAMA Neurol. 2018 Mar 1;75(3):312-319. doi: 10.1001/jamaneurol.2017.4019.
6
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.
Brain Struct Funct. 2017 Apr;222(3):1207-1218. doi: 10.1007/s00429-016-1271-4. Epub 2016 Jul 11.
7
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
Neurology. 2012 May 1;78(18):1434-40. doi: 10.1212/WNL.0b013e318253d54b. Epub 2012 Mar 21.
8
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
Mov Disord. 2015 Feb;30(2):253-8. doi: 10.1002/mds.26097. Epub 2014 Dec 9.
9
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Lancet Neurol. 2008 Jul;7(7):583-90. doi: 10.1016/S1474-4422(08)70117-0. Epub 2008 Jun 6.
10
Cognitive Impairments in LRRK2-Related Parkinson's Disease: A Study in Chinese Individuals.
Behav Neurol. 2015;2015:621873. doi: 10.1155/2015/621873. Epub 2015 Aug 6.

引用本文的文献

1
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.
Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.
2
Carriers of pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease.
medRxiv. 2025 Mar 10:2025.03.09.25323610. doi: 10.1101/2025.03.09.25323610.
4
Bidirectional relationship between olfaction and Parkinson's disease.
NPJ Parkinsons Dis. 2024 Dec 5;10(1):232. doi: 10.1038/s41531-024-00838-4.
8
Investigation of the genetic aetiology of Lewy body diseases with and without dementia.
Brain Commun. 2024 May 31;6(4):fcae190. doi: 10.1093/braincomms/fcae190. eCollection 2024.
9
Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers.
NPJ Parkinsons Dis. 2024 Jun 29;10(1):127. doi: 10.1038/s41531-024-00743-w.
10
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Neurology. 2024 Jul 23;103(2):e209609. doi: 10.1212/WNL.0000000000209609. Epub 2024 Jun 13.

本文引用的文献

1
Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.
JAMA Neurol. 2015 Jan;72(1):100-5. doi: 10.1001/jamaneurol.2014.2704.
2
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
JAMA Neurol. 2014 Nov;71(11):1405-12. doi: 10.1001/jamaneurol.2014.1455.
3
Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.
4
Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation.
Mov Disord. 2014 Jul;29(8):1057-60. doi: 10.1002/mds.25931. Epub 2014 Jun 5.
5
Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.
Neurobiol Aging. 2014 May;35(5):1125-31. doi: 10.1016/j.neurobiolaging.2013.11.015. Epub 2013 Nov 22.
8
LRRK2: cause, risk, and mechanism.
J Parkinsons Dis. 2013;3(2):85-103. doi: 10.3233/JPD-130192.
9
10
APOE ε4 increases risk for dementia in pure synucleinopathies.
JAMA Neurol. 2013 Feb;70(2):223-8. doi: 10.1001/jamaneurol.2013.600.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验